Specifically, circATG4B‐222aa functioned as a decoy for autophagy related 4B cysteine peptidase (ATG4B) protein and competed with transmemberane Emp24‐like trafficking protein 10 (TMED10), inducing the autophagy within recipient cells and reducing the pharmacological sensitivity of CRC cells to oxaliplatin [206]. The gene discussed is ATG4B; the disease is colorectal carcinoma.